57610 Federal Register / Vol. 65, No. 186 / Monday, September 25, 2000 / Notices

• Developed the capacity to provide

technical assistance to AAPI community

groups on organizational and

communication infrastructure

development and how to access health

and health services programs.

• Developed a strategy to raise

awareness in AAPI communities for

assuring AAPI representation in clinical

trials and research activities.

• A network of community health

centers that provides a foundation upon

which it develops, promotes, and

manages health intervention, education,

and training programs which are aimed

at preventing and reducing morbidity

and mortality among AAPIs.

• An extensive knowledge-base of

essential health services, health care

accessibility issues, and professional

development initiatives that deal

exclusively with AAPI populations,

attributes that are necessary for effective

intervention with this population group.

Where To Obtain Additional

Information

If you are interested in obtaining

additional information regarding this

cooperative agreement, contact Ms.

Cynthia Amis, Office of Minority

Health, 5515 Security Lane, Suite 1000,

Rockville, Maryland 20852 or telephone

(301) 594–0769.

Dated: September 12, 2000.

Nathan Stinson Jr.,

Deputy Assistant Secretary for Minority

Health.

[FR Doc. 00–24549 Filed 9–22–00; 8:45 am]

BILLING CODE 4160–17–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[60Day–00–51]

Proposed Data Collections Submitted

for Public Comment and

Recommendations

In compliance with the requirement

of Section 3506 (c) (2) (A) of the

Paperwork Reduction Act of 1995, the

Centers for Disease Control and

Prevention (CDC) is providing an

opportunity for public comment on

proposed data collection projects. To

request more information on the

proposed projects or to obtain a copy of

the data collection plans and

instruments, call the CDC Assistant

Reports Clearance Officer at 404–639–

7090.

Comments are invited on: (i) Whether

the proposed collection of information

is necessary for the proper performance

of the functions of the CDC, including

whether the information shall have a

practical utility; (ii) the accuracy of the

agency’s estimate of the burden of the

proposed collection of information; (iii)

ways to enhance the quality, utility, and

clarity of the information to be

collected; and (iv) ways to minimize the

burden of the collection of information

on respondents, including the use of

automated collection techniques or

other forms of information technology.

Send comments to Seleda M. Perryman,

CDC Assistant Reports Clearance

Officer, 1600 Clifton Road, MS–D24,

Atlanta, Georgia 30333. Written

comments should be received within 60

days of this notice.

Proposed Project

Travelers’ Health Survey—New—

National Center for Infectious Diseases

(NCID). Approximately 50 million

Americans travel abroad each year and

more than 25 million of these travel to

rural areas or developing countries

where the risk is greater for contracting

infectious diseases. Many of these

diseases are preventable through

vaccines, drugs, and other preventive

measures. According to surveillance

data from the CDC, over 99 percent of

malaria, 72 percent of typhoid, and 7

percent of hepatitis A cases in the U.S.

are acquired abroad. Information on

preventing illness during travel is

available free or at little cost through

public health departments, a CDC tollfree fax system, and the Internet.

However, many travelers may be

unaware of the health risks they face

when traveling because they either lack

access to pretravel health services or do

not understand the measures necessary

to avoid health risks. Evidence shows

first-and second-generation U.S.

immigrant travelers, when traveling to

their countries of origin to visit friends

and relatives, may be at greater risk than

the general public, for contracting

infectious diseases.

The objectives of this project are to

determine (i) whether travelers seek

pretravel health information, (ii) where

they access this information, (iii)

travelers’ baseline knowledge of

prevention measures for diseases

commonly associated with travel, and

(iv) whether specific groups of travelers

(i.e. first-and second-generation

immigrants) lack information on or

access to pretravel health

recommendations and services. To

accomplish these objectives, in

partnership with Delta Airlines, CDC

proposes to conduct voluntary, selfadministered, anonymous, in-flight

surveys of U.S. citizens and residents

traveling abroad to areas where malaria,

typhoid fever, and hepatitis A are

endemic.

This preliminary project will focus on

first-and second-generation U.S.

immigrants from India visiting friends

and relatives in India, where all three

diseases are endemic. A study period of

2 to 3 months is estimated. Data from

this project will fulfill Healthy People

2010 objectives for travelers. In

addition, it will enable CDC to develop

appropriate educational interventions

for high-risk travelers and to gain a

better understanding of the role of travel

in emerging infectious diseases. The

survey tool will take approximately 15

minutes to complete.

There are no costs to respondents,

only the time it takes to complete the

survey.

Number of respondents

Number of

responses/

respondent

Average

burden/

response (in

hours)

Total burden

hours

5,600 ............................................................................................................................................ 1 16/16 1,400

Federal Register / Vol. 65, No. 186 / Monday, September 25, 2000 / Notices 57611

Dated: September 19, 2000.

Nancy Cheal,

Acting Associate Director for Policy Planning,

and Evaluation, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 00–24531 Filed 9–22–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[30DAY–72–00]

Agency Forms Undergoing Paperwork

Reduction Act Review

The Centers for Disease Control and

Prevention (CDC) publishes a list of

information collection requests under

review by the Office of Management and

Budget (OMB) in compliance with the

Paperwork Reduction Act (44 U.S.C.

Chapter 35). To request a copy of these

requests, call the CDC Reports Clearance

Officer at (404) 639–7090. Send written

comments to CDC, Desk Officer; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503. Written

comments should be received within 30

days of this notice.

Proposed Project

Exposure to Aerosolized Brevetoxins

During Red Tide Events—New—

National Center for Environmental

Health (NCEH). Gymnodinium breve is

the marine dinoflagellate responsible for

extensive blooms (called red tides) that

form in the Gulf of Mexico. G. breve

produces potent toxins, called

brevetoxins, that have been responsible

for killing millions of fish and other

marine organisms. The biochemical

activity of brevetoxins is not completely

understood and there is very little

information regarding human health

effects from environmental exposures,

such as inhaling brevetoxin that has

been aerosolized and swept onto the

coast by offshore winds. The National

Center for Environmental Health

(NCEH), Centers for Disease Control and

Prevention (CDC) is planning to recruit

100 people who work along the coast of

Florida and who potentially will be

occupationally exposed to aerosolized

red tide toxins some time during the

year following recruitment.

NCEH plans on administering a base

line respiratory health questionnaire

and conducting pre- and post-shift

pulmonary function tests during a time

when there is no red tide reported near

the area. When a red tide develops, we

plan to administer a symptom survey

and conduct pulmonary function testing

(PFT) on a group of study participants

who are working in the area where the

red tide is near shore, and on a control

group of study participants who are not

working in an area where the red tide

is near shore (i.e., are not exposed to the

red tide). We will then compare (1)

symptom reports before and during the

red tide and (2) the changes in baseline

PFT values during the work shift

(differences between pre- and post-shift

PFT results without exposure to red

tide) with the changes in PFT values

during the work shift when individuals

are exposed to red tide. In addition, we

plan to assist in collecting biological

specimens (inflammatory cells from

nose and throat swabs) to assess

whether they can be used to verify

exposure and to demonstrate a

biological effect (i.e., inflammatory

response) from exposure to red tide.

There are no costs to respondents. The

total burden is estimated to be 201

hours.

Respondents Number of

respondents

Number of

responses per

respondent

Average

burden per

response

(in hrs.)

Pulmonary History Questionnaire ................................................................................................ 100 1 20/60

Symptom Questionnaire .............................................................................................................. 100 20 5/60

Dated: September 19, 2000.

Nancy Cheal,

Acting Associate Director for Policy,

Planning, and Evaluation, Centers for Disease

Control and Prevention (CDC).

[FR Doc. 00–24530 Filed 9–22–00; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Advisory Committee on Immunization

Practices: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(P.L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting:

Name: Advisory Committee on

Immunization Practices (ACIP)

Teleconference.

Time and Date: 3:15 p.m.–5 p.m.,

September 28, 2000.

Place: Teleconference call will originate at

the Centers for Disease Control and

Prevention in Atlanta, Georgia. Please see

‘‘Supplementary Information’’ for details on

accessing the teleconference.

Status: Open to the public, teleconference

access limited only by availability of

telephone ports.

Purpose: The Committee is charged with

advising the Director, CDC, on the

appropriate uses of immunizing agents. In

addition, under 42 U.S.C. § 1396s, the

Committee is mandated to establish and

periodically review and, as appropriate,

revise the list of vaccines for administration

to vaccine-eligible children through the

Vaccines for Children (VFC) program, along

with schedules regarding the appropriate

periodicity, dosage, and contraindications

applicable to the vaccines.

Matters to be Discussed: The

teleconference agenda will include a

discussion of influenza vaccine

recommendations for the 2000–2001

influenza season. Discussion will include

priority groups for vaccination,

implementation measures, and strategies for

promoting vaccine delivery later in the

influenza season.

Agenda items are subject to change as

priorities dictate.

SUPPLEMENTARY INFORMATION: This

conference call is scheduled for 3:15

p.m. Eastern Standard Time. To access

the teleconference you must dial 1/888/

381–5770 and enter conference code

53651. You will then be automatically

connected to the call. It is necessary to

meet on an expedited basis, to refine

vaccine recommendations prior to the

influenza season. Therefore, notice is

published less than 15 days prior to the

teleconference.

CONTACT PERSON FOR MORE INFORMATION:

Gloria A. Kovach, Program Analyst,

Epidemiology and Surveillance

Division, National Immunization

Program, CDC, 1600 Clifton Road, NE,

m/s E61, Atlanta, Georgia 30333.

Telephone 404/639–8096. The Director,

Management Analysis and Services

office has been delegated the authority

to sign Federal Register notices

pertaining to announcements of

meetings and other committee

management activities for both the